Synta CEO resigns before key data readouts
This article was originally published in Scrip
Executive Summary
Synta Pharmaceuticals president, CEO and board member Safi Bahcall submitted his immediate resignation, the company reported following the stock market's close on 3 March, sending Synta down 6.5% in after-hours trading to $5.75 per share.